{"pmid":32328338,"pmcid":"PMC7167876","title":"Anal swab findings in an infant with COVID-19.","text":["Anal swab findings in an infant with COVID-19.","Introduction: The transmission pathways of coronavirus disease 2019 (COVID-19) remain not completely clear. In this case study the test for the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pharyngeal swab and anal swab were compared. Case presentation: A 3-month-old girl was admitted to our hospital with COVID-19. Her parents had both been diagnosed with COVID-19. The results of pharyngeal swab and anal swab of the little girl were recorded and compared during the course of the disease. The oropharyngeal specimen showed negative result for SARS-CoV-2 on the 14th day after onset of the illness. However, the anal swab was still positive for SARS-CoV-2 on the 28th day after the onset of the illness. Conclusion: The possibility of fecal-oral transmission of COVID-19 should be assessed. Personal hygiene during home quarantine merits considerable attention.","Pediatr Investig","Fan, Qihong","Pan, Yan","Wu, Qingcui","Liu, Shan","Song, Xu","Xie, Zhongguo","Liu, Yang","Zhao, Liang","Wang, Zhonghong","Zhang, Yifei","Wu, Zuchuang","Guan, Lei","Lv, Xiaolong","32328338"],"abstract":["Introduction: The transmission pathways of coronavirus disease 2019 (COVID-19) remain not completely clear. In this case study the test for the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pharyngeal swab and anal swab were compared. Case presentation: A 3-month-old girl was admitted to our hospital with COVID-19. Her parents had both been diagnosed with COVID-19. The results of pharyngeal swab and anal swab of the little girl were recorded and compared during the course of the disease. The oropharyngeal specimen showed negative result for SARS-CoV-2 on the 14th day after onset of the illness. However, the anal swab was still positive for SARS-CoV-2 on the 28th day after the onset of the illness. Conclusion: The possibility of fecal-oral transmission of COVID-19 should be assessed. Personal hygiene during home quarantine merits considerable attention."],"journal":"Pediatr Investig","authors":["Fan, Qihong","Pan, Yan","Wu, Qingcui","Liu, Shan","Song, Xu","Xie, Zhongguo","Liu, Yang","Zhao, Liang","Wang, Zhonghong","Zhang, Yifei","Wu, Zuchuang","Guan, Lei","Lv, Xiaolong"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328338","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ped4.12186","keywords":["anal swab","covid-19","fecal-oral transmission","sars-cov-2"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664996914747146241,"score":8.518259,"similar":[{"pmid":32330305,"title":"SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","text":["SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved.","J Med Virol","Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang","32330305"],"abstract":["PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330305","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25936","keywords":["sars-cov-2","prognosis","real-time polymerase chain reaction","specimens","urine"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1664996914914918401,"score":439.3355},{"pmid":32102625,"pmcid":"PMC7054964","title":"Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.","text":["Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.","The novel coronavirus (2019-nCoV) infection caused pneumonia. we retrospectively analyzed the virus presence in the pharyngeal swab, blood, and the anal swab detected by real-time PCR in the clinical lab. Unexpectedly, the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). Importantly, all of the 6 patients with detectable viral RNA in the blood cohort progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity (p-value = 0.0001). Meanwhile, 8 of the 11 patients with annal swab virus-positive was in severe clinical stage. However, the concentration of viral RNA in the anal swab (Ct value = 24 + 39) was higher than in the blood (Ct value = 34 + 39) from patient 2, suggesting that the virus might replicate in the digestive tract. Altogether, our results confirmed the presence of virus RNA in extra-pulmonary sites.","Emerg Microbes Infect","Chen, Weilie","Lan, Yun","Yuan, Xiaozhen","Deng, Xilong","Li, Yueping","Cai, Xiaoli","Li, Liya","He, Ruiying","Tan, Yizhou","Deng, Xizi","Gao, Ming","Tang, Guofang","Zhao, Lingzhai","Wang, Jinlin","Fan, Qinghong","Wen, Chunyan","Tong, Yuwei","Tang, Yangbo","Hu, Fengyu","Li, Feng","Tang, Xiaoping","32102625"],"abstract":["The novel coronavirus (2019-nCoV) infection caused pneumonia. we retrospectively analyzed the virus presence in the pharyngeal swab, blood, and the anal swab detected by real-time PCR in the clinical lab. Unexpectedly, the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). Importantly, all of the 6 patients with detectable viral RNA in the blood cohort progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity (p-value = 0.0001). Meanwhile, 8 of the 11 patients with annal swab virus-positive was in severe clinical stage. However, the concentration of viral RNA in the anal swab (Ct value = 24 + 39) was higher than in the blood (Ct value = 34 + 39) from patient 2, suggesting that the virus might replicate in the digestive tract. Altogether, our results confirmed the presence of virus RNA in extra-pulmonary sites."],"journal":"Emerg Microbes Infect","authors":["Chen, Weilie","Lan, Yun","Yuan, Xiaozhen","Deng, Xilong","Li, Yueping","Cai, Xiaoli","Li, Liya","He, Ruiying","Tan, Yizhou","Deng, Xizi","Gao, Ming","Tang, Guofang","Zhao, Lingzhai","Wang, Jinlin","Fan, Qinghong","Wen, Chunyan","Tong, Yuwei","Tang, Yangbo","Hu, Fengyu","Li, Feng","Tang, Xiaoping"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32102625","week":"20209|Feb 24 - Mar 01","doi":"10.1080/22221751.2020.1732837","keywords":["2019-ncov","anal swab","blood viral rna","laboratory test","pharyngeal swab"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664640875137859584,"score":432.02765},{"pmid":32243607,"title":"The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","text":["The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun","32243607"],"abstract":["BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243607","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25825","keywords":["coronavirus disease 2019","fecal-oral transmission","severe acute respiratory syndrome coronavirus 2","viral rna","viral shedding"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","Feces"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638249317957632,"score":407.4878},{"pmid":32305459,"pmcid":"PMC7151521","title":"Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report.","text":["Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report.","As the 2019 novel coronavirus disease (COVID-19) rapidly spread across China and to more than 70 countries, an increasing number of pregnant women were affected. The vertical transmission potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of great concern to the obstetrics, neonatologists, and public health agencies. Though some studies indicated the risk of vertical transmission is low, few cases have been reported with comprehensive serial tests from multiple specimens. In this case, a female preterm infant was born to a mother with confirmed COVID-19. She presented with mild respiratory distress and received general management and a short period of nasal continuous positive airway pressure support. During her stay at the hospital, a series of SARS-CoV-2 nucleic test from her throat and anal swab, serum, bronchoalveolar lavage fluid, and urine were negative. The nucleic acid test from the mother's amniotic fluid, vaginal secretions, cord blood, placenta, serum, anal swab, and breast milk were also negative. The most comprehensively tested case reported to date confirmed that the vertical transmission of COVID is unlikely, but still, more evidence is needed.","J Infect Public Health","Peng, Zhoujie","Wang, Jianhui","Mo, Yunbo","Duan, Wei","Xiang, Guangjun","Yi, Ming","Bao, Lei","Shi, Yuan","32305459"],"abstract":["As the 2019 novel coronavirus disease (COVID-19) rapidly spread across China and to more than 70 countries, an increasing number of pregnant women were affected. The vertical transmission potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of great concern to the obstetrics, neonatologists, and public health agencies. Though some studies indicated the risk of vertical transmission is low, few cases have been reported with comprehensive serial tests from multiple specimens. In this case, a female preterm infant was born to a mother with confirmed COVID-19. She presented with mild respiratory distress and received general management and a short period of nasal continuous positive airway pressure support. During her stay at the hospital, a series of SARS-CoV-2 nucleic test from her throat and anal swab, serum, bronchoalveolar lavage fluid, and urine were negative. The nucleic acid test from the mother's amniotic fluid, vaginal secretions, cord blood, placenta, serum, anal swab, and breast milk were also negative. The most comprehensively tested case reported to date confirmed that the vertical transmission of COVID is unlikely, but still, more evidence is needed."],"journal":"J Infect Public Health","authors":["Peng, Zhoujie","Wang, Jianhui","Mo, Yunbo","Duan, Wei","Xiang, Guangjun","Yi, Ming","Bao, Lei","Shi, Yuan"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305459","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jiph.2020.04.004","keywords":["covid-19","neonate","sars-cov-2","vertical transmission"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China","placenta"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664641855691685888,"score":390.4833},{"pmid":32065057,"pmcid":"PMC7048229","title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.","text":["Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.","In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tract and then induced pneumonia, thus molecular diagnosis based on oral swabs was used for confirmation of this disease. Likewise, patient will be released upon two times of negative detection from oral swabs. However, many coronaviruses can also be transmitted through oral-fecal route by infecting intestines. Whether 2019-nCoV infected patients also carry virus in other organs like intestine need to be tested. We conducted investigation on patients in a local hospital who were infected with this virus. We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral-fecal route. We also showed serology test can improve detection positive rate thus should be used in future epidemiology. Our report provides a cautionary warning that 2019-nCoV may be shed through multiple routes.","Emerg Microbes Infect","Zhang, Wei","Du, Rong-Hui","Li, Bei","Zheng, Xiao-Shuang","Yang, Xing-Lou","Hu, Ben","Wang, Yan-Yi","Xiao, Geng-Fu","Yan, Bing","Shi, Zheng-Li","Zhou, Peng","32065057"],"abstract":["In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tract and then induced pneumonia, thus molecular diagnosis based on oral swabs was used for confirmation of this disease. Likewise, patient will be released upon two times of negative detection from oral swabs. However, many coronaviruses can also be transmitted through oral-fecal route by infecting intestines. Whether 2019-nCoV infected patients also carry virus in other organs like intestine need to be tested. We conducted investigation on patients in a local hospital who were infected with this virus. We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral-fecal route. We also showed serology test can improve detection positive rate thus should be used in future epidemiology. Our report provides a cautionary warning that 2019-nCoV may be shed through multiple routes."],"journal":"Emerg Microbes Infect","authors":["Zhang, Wei","Du, Rong-Hui","Li, Bei","Zheng, Xiao-Shuang","Yang, Xing-Lou","Hu, Ben","Wang, Yan-Yi","Xiao, Geng-Fu","Yan, Bing","Shi, Zheng-Li","Zhou, Peng"],"date":"2020-02-18T11:00:00Z","year":2020,"_id":"32065057","week":"20208|Feb 17 - Feb 23","doi":"10.1080/22221751.2020.1729071","keywords":["2019-ncov","wuhan pneumonia","epidemiology","intestine","swabs"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","swab"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875265785856,"score":361.0547}]}